# Neostigmine

NDC: 43598-529
Generic name: Neostigmine
Labeler / Manufacturer: Dr.Reddy's Laboratories Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20180904

FDA application: ANDA209135

## Active ingredients

- NEOSTIGMINE METHYLSULFATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43598-529"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43598-529
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=81243f47-bd25-bd02-518a-087badcca755